| Authors: |
Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Yue H; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America., Nowak RP; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America., Brais L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Ma C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Johnson S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Harrod J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Burman SSR; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America., Hendrickson LM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Fischinger S; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States of America., Alter G; Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology, and Harvard University, Cambridge, MA, United States of America., Hahn W; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Broad Institute of Harvard and MIT, Cambridge, MA, United States of America., Johnson BE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, United States of America., Fischer ES; Department of Cancer Biology, Dana-Farber Cancer Institute, Boston, MA, United States of America.; Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, United States of America. |
